North America Cancer Diagnostics Market 2024: Market Overview, Market Segmentation 2017

North America cancer diagnostics is expected to reach USD 17.72 billion by 2024 from USD 7.59 billion in 2016, at a CAGR of 11.2% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Customize Report of “North America Cancer Diagnostics Market” Also Available On Request (As per Requirement) Get 10% Discount on Report

Ask for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=north-america-cancer-diagnostics-market

North-America-cancer-diagnostics

North America Cancer Diagnostics Market By Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melonoma), By Geography – Industry Trends and Forecast to 2024

The major factors driving the growth of this market are the technological advancement in the field of early detection of cancer and high investment in cancer research by North America. These factors increase the demand for cancer diagnostic products. On the other hand, stringent regulations imposed by international and local authorities and shortage of skilled and trained professionals may hinder the growth of the market.

Market Segmentation: North America Cancer Diagnostics Market

The North America cancer diagnostics market is segmented on the basis of technology, application and geography. The North America cancer diagnostics market is segmented into 2 types, namely platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 69.4% and is expected to continue this trend till 2024.

Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography and ultrasound.

Have any Query Regarding this Report? Speak to Analyst Visit @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=north-america-cancer-diagnostics-market

TABLE OF CONTENTS

  1. INTRODUCTION

1.1.         OBJECTIVES OF THE STUDY

1.2.         MARKET DEFINITION

1.3.         OVERVIEW OF NORTH AMERICA CANCER DIAGNOSTICS MARKET

1.4.         CURRENCY AND PRICING

1.5.         LIMITATION

1.6.         MARKETS COVERED

  1. MARKET SEGMENTATION

2.1.         MARKETS COVERED

2.2.         GEOGRAPHIC SCOPE

2.3.         YEARS CONSIDERED FOR THE STUDY

2.4.         CURRENCY AND PRICING

2.5.         RESEARCH METHODOLOGY

2.6.         PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7.         SECONDARY SOURCES

2.8.         ASSUMPTIONS

  1. MARKET OVERVIEW

3.1.         DRIVERS

3.2.         RESTRAINTS

3.3.         OPPORTUNITIES

3.4.         CHALLENGES

  1. PREMIUM INSIGHTS
  2. EXECUTIVE SUMMARY
  3. NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
  4. NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY APPLICATION
  5. NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY
  6. NORTH AMERICA CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE

9.1.         COMPANY SHARE ANALYSIS: NORTH AMERICA CANCER DIAGNOSTICS IMAGING MARKET

  1. COMPANY PROFILES

10.1.      C. R. BARD, INC.

10.2.      ILLUMINA, INC.

10.3.      QIAGEN

10.4.      ABBOTT

10.5.      SIEMENS HEALTHCARE GMBH

10.6.      AGILENT TECHNOLOGIES

10.7.      THERMO FISHER SCIENTIFIC INC.

10.8.      BECTON, DICKINSON AND COMPANY

10.9.      GE HEALTHCARE

10.10.    F. HOFFMANN-LA ROCHE LTD

10.11.    HOLOGIC INC.

10.12.    KONINKLIJHE PHILIPS N.V.

  1. RELATED REPORTS

To Know More Visit @ http://databridgemarketresearch.com/reports/north-america-cancer-diagnostics-market/

Key Drivers: North America Cancer Diagnostics Market

Some of the major factors driving the market for cancer diagnostics market are technological advancement in the field of early detection of cancer and high investment in cancer research by North America. These factors increase the demand for cancer diagnostics products. Increasing prevalence of cancer, key players focusing are on strategic decisions is the major factor driving the growth of the cancer diagnostics market.

  • Stringent regulations imposed by the international and local authorities and shortage of the skilled and trained professionals are the factors which may hinder the growth of this market.
  • Many companies are increasingly focusing on next generation sequencing (NGS) and biopsy products in order to strengthen their product portfolios in the cancer diagnostics market.
  • Increasing demand for magnetic resonance imaging (MRI) and next generation sequencing (NGS) will drive the market in future.

Read more about Report Visit @ http://databridgemarketresearch.com/reports/north-america-cancer-diagnostics-market/

Key Points: North America Cancer Diagnostics Market

GE Healthcare is going to dominate the cancer diagnostics market, by imaging following with Siemens Healthcare GmbH along with others such as Hologic, Inc, Becton, Dickinson & Company. Thermo Fisher Scientific, Inc. is going to dominate the cancer diagnostics market, by platform based following with Illumina, Inc. along with others such as Roche Diagnostics, Abbott Laboratories, Inc. QIAGEN.

  • Next generation sequencing (NGS) market is growing with the highest CAGR.
  • North America biopsy is driving the market with the highest market share.
  • Magnetic resonance imaging (MRI) is dominating the cancer diagnostics imaging market.

Related Report

Global Wearable Devices Market – Trends and Forecast to 2024

Global Wearable Devices Market, By Product Type (Wrist wear, Eyewear, Footwear, Neckwear, Body wear, Others), By Industry (Consumer Products, Healthcare, Industrial, and Others), By Type (Smart Textile (Passive, Active, Ultra Smart) (Sensing, Energy Harvesting, Luminiscence, Thermo Electricity), Non-Textile), By Technology, By Component, By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-wearable-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog: http://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

%d bloggers like this: